AU2001282388A1 - Pro-apoptotic fragments of the dengue virus envelope glycoproteins - Google Patents

Pro-apoptotic fragments of the dengue virus envelope glycoproteins

Info

Publication number
AU2001282388A1
AU2001282388A1 AU2001282388A AU8238801A AU2001282388A1 AU 2001282388 A1 AU2001282388 A1 AU 2001282388A1 AU 2001282388 A AU2001282388 A AU 2001282388A AU 8238801 A AU8238801 A AU 8238801A AU 2001282388 A1 AU2001282388 A1 AU 2001282388A1
Authority
AU
Australia
Prior art keywords
polypeptide
cell
polynucleotide
egfp
den
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282388A
Other languages
English (en)
Inventor
Adeline Catteau
Marie-Pierre Courageot
Philippe Despres
Vincent Deubel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of AU2001282388A1 publication Critical patent/AU2001282388A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001282388A 2000-06-16 2001-06-18 Pro-apoptotic fragments of the dengue virus envelope glycoproteins Abandoned AU2001282388A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21212900P 2000-06-16 2000-06-16
US60/212,129 2000-06-16
PCT/IB2001/001570 WO2001096376A2 (en) 2000-06-16 2001-06-18 Pro-apoptotic fragments of the dengue virus envelope glycoproteins

Publications (1)

Publication Number Publication Date
AU2001282388A1 true AU2001282388A1 (en) 2001-12-24

Family

ID=22789669

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001282388A Abandoned AU2001282388A1 (en) 2000-06-16 2001-06-18 Pro-apoptotic fragments of the dengue virus envelope glycoproteins

Country Status (6)

Country Link
US (2) US6673895B2 (cg-RX-API-DMAC7.html)
EP (1) EP1311539A2 (cg-RX-API-DMAC7.html)
JP (1) JP2004503233A (cg-RX-API-DMAC7.html)
AU (1) AU2001282388A1 (cg-RX-API-DMAC7.html)
CA (1) CA2412257A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001096376A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002211490A1 (en) * 2000-10-04 2002-04-15 The Trustees Of The University Of Pennsylvania Compositions and methods of using capsid protein from flaviviruses and pestiviruses
US7189403B2 (en) * 2003-06-30 2007-03-13 Institut Pasteur Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
CA2508266A1 (fr) 2005-06-20 2006-12-20 Institut Pasteur Polypeptides chimeriques et leurs applications therapeutiques contre une infection a flaviviridae
DK1939214T3 (da) 2006-12-22 2013-10-14 Pasteur Institut Celler og metodik til at generere ikke-segmenterede negativstrengede RNA-vira

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136561A (en) * 1995-05-24 2000-10-24 Hawaii Biotechnology Group, Inc. Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems
CA2290090A1 (fr) * 1999-12-07 2001-06-07 Marie-Pierre Courageot Lignee cellulaire stable inductible n2aprm+e incluant l'adnc codant pour les glycoproteines prm et e du virus den-1: un systeme modele pour tester les proprietes inhibitrices des agents anti-viraux cibles pour les glycoproteines de l'enveloppe des flaviviridae

Also Published As

Publication number Publication date
WO2001096376A3 (en) 2003-03-13
WO2001096376A9 (en) 2003-10-23
CA2412257A1 (en) 2001-12-20
JP2004503233A (ja) 2004-02-05
US20040049016A1 (en) 2004-03-11
EP1311539A2 (en) 2003-05-21
US6673895B2 (en) 2004-01-06
WO2001096376A2 (en) 2001-12-20
US20020086403A1 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
US11718647B2 (en) Virus-like particles and methods of use
RU2209082C2 (ru) Химерные флавивирусные вакцины
LO et al. Differential subcellular localization of hepatitis C virus core gene products
AU667836B2 (en) Chimeric and/or growth-restricted flaviviruses
CA2443323C (en) Nucleic acid vaccines for prevention of flavivirus infection
DE3886363T2 (de) NANBV-Diagnostika und Vakzine.
EP1575979B1 (en) West nile virus vaccine
IL139844A (en) Nucleic acid vaccines for prevention of flavivirus infection
TWI450724B (zh) 新的融合蛋白質及其用於製備抗ｃ型肝炎疫苗的用途
US7785604B2 (en) Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
Keil et al. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector
JPH05344899A (ja) Ｃ型肝炎ウイルス外被タンパク質の産生法
US6673895B2 (en) Pro-apoptotic fragments of the dengue virus envelope glycoproteins
CA2070952A1 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
AU3757199A (en) Chimeras of hepatitis c virus and bovine viral diarrhea virus
US20040101862A1 (en) Pro-apoptoic fragments of the dengue virus envelope glycoproteins
FI117974B (fi) Parannettu rokote immunisointiin TBE-virusinfektioita vastaan ja menetelmä sen valmistamiseksi
KR100209095B1 (ko) C형 간염 바이러스의 프로테아제의 활성을 측정할 수 있는 c형 간염 대체 바이러스, 그 재조합 유전자 및 그 용도
CA2268737A1 (en) Replication-competent recombinant sabin type 1 strain of poliovirus
CN111778279B (zh) 一种HTLV-1 Env介导的细胞-细胞融合模型、制备方法及应用
US7108995B2 (en) Small peptides having apoptotic activities and their applications
RU2375449C2 (ru) КОДИРУЮЩАЯ ДНК (кДНК) ДЛЯ ПОЛУЧЕНИЯ ВИРУСОПОДОБНЫХ ЧАСТИЦ ВИРУСА ГЕПАТИТА С, СПОСОБ ПОЛУЧЕНИЯ ВИРУСОПОДОБНЫХ ЧАСТИЦ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ
SK277781B6 (en) Peptides and polypeptides, vaccines and nucleous acid
Clum Characterization of the Dengue virus type-2 two component NS2B/NS3 proteinase
HK1083192B (en) West nile virus vaccine

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application